Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Shanghai United Imaging Healthcare Co. Ltd. A
688271Shanghai United Imaging Healthcare Co., Ltd. engages in the provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. Its molecular imaging products include uEXPLORER, uPMR 790, uMI 780, uMI Vista, and uMI 550; and magnetic resonance imaging solutions comprise uMR 5T, uMR Omega, uMR 790, uMR 780, and uMR 770, uMR 680, uMR 670, uMR588, uMR 580, and uMR570. The company also offers computed tomography equipment, such as uCT 960+, uCT 780, uCT 760, uCT 530, uCT 528, and uCT 520; digital radiography equipment, including uDR 780i Pro, uDR 596i, uDR 566i, uDR 592h, uDR 266i, uDR 380i, uMammo 890i, uMammo 590i, and uMC 560i; and radiotherapy systems comprising uRT-linac 506c, uRT-linac 306, and Intelligent RT Cloud Ecosystem. In addition, it provides uVision, a remote vision system that enables real-time positioning observation and automatic field of view identification; ultra-low dose, high resolution three-dimensional breast imaging technology application solution; uStereo stereotaxic biopsy system, a biopsy positioning system that provides an intelligent and precise positioning workflow for breast biopsy; and Remote Vision and Exposure Control technology application, a handheld X-ray from UIH that enables accurate positioning while reducing exposure radiation. Further, the company offers United Neuro, a medical imaging software, used to analyze functional magnetic resonance imaging and diffusion tensor imaging data; and U-VIEWER, a software that helps in viewing DICOM images. Additionally, it provides training, monitoring, maintenance, and troubleshooting services. Shanghai United Imaging Healthcare Co., Ltd. was founded in 2011 and is headquartered in Shanghai, China. Address: 2258 Chengbei Road, Shanghai, China, 201807
Analytics
Precio Objetivo de WallStreet
1 078.6 CNYRelación P/E
64.1451Rentabilidad por dividendo
0.28 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave 688271
Análisis de dividendos 688271
Aumento del dividendo durante 5 años
–Crecimiento continuo
1 AñoRatio de pago medio en 5 años
8 %Tendencia del payout 688271
Valoración de la acción 688271
Finanzas 688271
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |